Upregulation and inhibition of the nuclear translocation of Oct4 during multistep gastric carcinogenesis

Al-Marzoqee,Fathyia  Y.; Khoder,Ghalia; Al-Awadhi,Haifa; John,Rony; Beg,Azam; Vincze,Aron; Branicki,Frank; Karam,Sherif  M.

doi:10.3892/ijo.2012.1608

Upregulation and inhibition of the nuclear translocation of Oct4 during multistep gastric carcinogenesis

Authors:
- Fathyia Y. Al-Marzoqee
- Ghalia Khoder
- Haifa Al-Awadhi
- Rony John
- Azam Beg
- Aron Vincze
- Frank Branicki
- Sherif M. Karam
View Affiliations

Affiliations: Department of Anatomy, Faculty of Medicine and Health Sciences, UAE University, Al-Ain, United Arab Emirates, Department of Anatomy, Faculty of Medicine and Health Sciences, UAE University, Al-Ain, United Arab Emirates, College of Information Technology, UAE University, Al-Ain, United Arab Emirates, Gastroenterology Unit, Tawam Hospital, Al-Ain, United Arab Emirates, Department of Surgery, Faculty of Medicine and Health Sciences, UAE University, Al-Ain, United Arab Emirates
Published online on: August 24, 2012 https://doi.org/10.3892/ijo.2012.1608
Pages: 1733-1743

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastric cancer is the fourth most commonly diagnosed malignancy and the second leading cause of cancer-related mortality worldwide. Recent research suggests that tissue stem cells and the self renewal transcription factor, octamer-binding transcription factor 4 (Oct4), could be involved in the development of certain tumors. The aim of this study was to investigate the expression pattern of Oct4 in normal human stomach and during multistep gastric carcinogenesis. Pyloric antral mucosal tissues were obtained from consenting individuals undergoing endoscopy (due to upper gastrointestinal symptoms) and gastrectomy (due to pyloric antral adenocarcinoma). Some tissue samples were processed to assemble an array of tissue sections representing multistep carcinogenesis and probed using anti-Oct4 antibodies and lectins specific for α-L-fucose or N-acetyl-D-glucosamine. Some tissue samples were processed for subcellular fractionation and western blot analysis using the same antibodies. The results revealed that Oct4-expressing cells were found in the proliferative cell compartment of the pit-gland units of microscopically normal gastric mucosal biopsies. Mucosal tissues with evidence of severe gastritis, metaplastic/dysplastic transformation and gastric cancer showed a significant increase in the expression of Oct4 (the labeled area increased from 2% in the control to 6 and 16% in the gastritis and cancerous tissues, respectively), suggesting a role for Oct4 in the early stages of cancer development. Furthermore, the data revealed an alteration in the subcellular distribution of Oct4, possibly due to the inhibition of cytoplasm-to-nucleus translocation during carcinogenesis. In conclusion, this study demonstrates an alteration in the expression pattern and nuclear translocation of Oct4 during gastric carcinogenesis and may be helpful in designing new modalities for the early detection and/or therapy of gastric cancer.

View Figures

View References

1.	Brenner H, Rothenbacher D and Arndt V: Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477. 2009. View Article : Google Scholar
2.	Correa P: Is gastric cancer preventable? Gut. 53:1217–1219. 2004. View Article : Google Scholar : PubMed/NCBI
3.	Kushima R, Vieth M, Borchard F, Stolte M, Mukaisho K and Hattori T: Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer. 9:177–184. 2006. View Article : Google Scholar : PubMed/NCBI
4.	Correa P, Piazuelo MB and Camargo MC: Etiopathogenesis of gastric cancer. Scand J Surg. 95:218–24. 2006.
5.	Fox JG and Wang TC: Inflammation, atrophy, and gastric cancer. J Clin Invest. 117:60–69. 2007. View Article : Google Scholar
6.	Karam SM: Mouse models demonstrating the role of stem/progenitor cells in gastric carcinogenesis. Front Biosci. 15:595–603. 2010. View Article : Google Scholar : PubMed/NCBI
7.	Lee ER and Leblond CP: Dynamic histology of the antral epithelium in the mouse stomach: II. Ultrastructure and renewal of isthmal cells. Am J Anat. 172:205–224. 1985. View Article : Google Scholar : PubMed/NCBI
8.	Karam SM: Lineage commitment and maturation of epithelial cells in the gut. Front Biosci. 4:D286–D298. 1999. View Article : Google Scholar : PubMed/NCBI
9.	Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, Sato T, Stange DE, Begthel H, van den Born M, Danenberg E, van den Brink S, Korving J, Abo A, Peters PJ, Wright N, Poulsom R and Clevers H: Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell. 6:25–36. 2010.
10.	Karam SM, Tomasetto C and Rio MC: Trefoil factor 1 is required for the commitment programme of mouse oxyntic epithelial progenitors. Gut. 53:1408–1415. 2004. View Article : Google Scholar : PubMed/NCBI
11.	Karam SM, Tomasetto C and Rio MC: Amplification and invasiveness of gastric epithelial progenitors during carcinogenesis in TFF1-knockout mice. Cell Prolif. 41:923–935. 2008. View Article : Google Scholar : PubMed/NCBI
12.	Al-Awadhi H, John R, Al-Marzooqi F, Vincze A, Branicki F and Karam SM: Sequential alterations in gastric biopsies and tumor tissues support the multistep process of carcinogenesis. Histol Histopath. 26:1153–1164. 2011.PubMed/NCBI
13.	Trosko JE and Chang CC: Stem cell theory of carcinogenesis. Toxicol Lett. 49:283–295. 1989. View Article : Google Scholar
14.	Sell S: On the stem cell origin of cancer. Am J Pathol. 176:2584–2594. 2010. View Article : Google Scholar : PubMed/NCBI
15.	Katoh M and Katoh M: WNT signaling pathway and stem cell signaling network. Clin Cancer Res. 13:4042–4045. 2007. View Article : Google Scholar : PubMed/NCBI
16.	Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M and Hamada H: A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell. 60:461–472. 1990. View Article : Google Scholar : PubMed/NCBI
17.	Thomas T, Nowka K, Lan L and Derwahl M: Expression of endoderm stem cell markers: evidence for the presence of adult stem cells in human thyroid glands. Thyroid. 16:537–544. 2006. View Article : Google Scholar : PubMed/NCBI
18.	Yu H, Fang D, Kumar SM, Li L, Nguyen TK, Acs G, Herlyn M and Xu X: Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol. 168:1879–1888. 2006. View Article : Google Scholar : PubMed/NCBI
19.	Sotomayor P, Godoy A, Smith GJ and Huss WJ: Oct4A is expressed by a subpopulation of prostate neuroendocrine cells. Prostate. 69:401–410. 2009. View Article : Google Scholar : PubMed/NCBI
20.	Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK and Trosko JE: Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis. 26:495–502. 2005.PubMed/NCBI
21.	Hochedlinger K, Yamada Y, Beard C and Jaenisch R: Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell. 121:465–477. 2005. View Article : Google Scholar
22.	Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G and Oosterhuis JW: POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 63:2244–2250. 2003.PubMed/NCBI
23.	Ezeh UI, Turek PJ, Reijo RA and Clark AT: Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer. 104:2255–2265. 2005. View Article : Google Scholar : PubMed/NCBI
24.	Iki K and Pour PM: Expression of Oct4, a stem cell marker, in the hamster pancreatic cancer model. Pancreatology. 6:406–413. 2006. View Article : Google Scholar : PubMed/NCBI
25.	Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN and Steindler DA: Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
26.	Stolte M and Meining A: The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol. 15:591–598. 2001.PubMed/NCBI
27.	Karam SM, Li Q and Gordon JI: Gastric epithelial morphogenesis in normal and transgenic mice. Am J Physiol. 272:G1209–G1220. 1997.PubMed/NCBI
28.	Farook VS, Alkhalaf M and Karam SM: Establishment of a gastric epithelial progenitor cell line from a transgenic mouse expressing the simian virus 40 large T antigen gene in the parietal cell lineage. Cell Prolif. 41:310–320. 2008. View Article : Google Scholar : PubMed/NCBI
29.	Liedtke S, Stephan M and Kogler G: Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem. 389:845–850. 2008. View Article : Google Scholar : PubMed/NCBI
30.	Zuk PA: The intracellular distribution of the ES cell totipotent markers OCT4 and Sox2 in adult stem cells differs dramatically according to commercial antibody used. J Cell Biochem. 106:867–877. 2009. View Article : Google Scholar : PubMed/NCBI
31.	Wang X and Dai J: Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem Cells. 28:885–893. 2010.PubMed/NCBI
32.	Chen Z, Xu WR, Qian H, Zhu W, Bu XF, Wang S, Yan YM, Mao F, Gu HB, Cao HL and Xu XJ: Oct4, a novel marker for human gastric cancer. J Surg Oncol. 99:414–419. 2009. View Article : Google Scholar : PubMed/NCBI
33.	Graham DY, Opekun AR, Yamaoka Y, Osato MS and el-Zimaity HM: Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther. 17:193–200. 2003. View Article : Google Scholar : PubMed/NCBI
34.	Ji H and Yardley JH: Iron medication-associated gastric mucosal injury. Arch Pathol Lab Med. 128:821–822. 2004.PubMed/NCBI
35.	Zangrossi S, Marabese M, Broggini M, Giordano R, D’Erasmo M, Montelatici E, Intini D, Neri A, Pesce M, Rebulla P and Lazzari L: Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells. 25:1675–1680. 2007. View Article : Google Scholar : PubMed/NCBI
36.	Asadi MH, Mowla SJ, Fathi F, Aleyasin A, Asadzadeh J and Atlasi Y: OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor. Int J Cancer. 128:2645–2652. 2011. View Article : Google Scholar : PubMed/NCBI
37.	Niwa H, Miyazaki J and Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 24:372–376. 2000. View Article : Google Scholar : PubMed/NCBI
38.	Ratajczak MZ, Shin DM, Liu R, Marlicz W, Tarnowski M, Ratajczak J and Kucia M: Epiblast/germ line hypothesis of cancer development revisited: lesson from the presence of Oct-4⁺ cells in adult tissues. Stem Cell Rev. 6:307–316. 2010. View Article : Google Scholar : PubMed/NCBI
39.	Sell S: Cancer and stem cell signaling: a guide to preventive and therapeutic strategies for cancer stem cells. Stem Cell Rev. 3:1–6. 2007. View Article : Google Scholar : PubMed/NCBI